KKR to invest $250m in Henry Schein.

KKR, a private equity firm, agreed to invest $250m in Henry Schein, a provider of healthcare products and services. “Our Board and management have great respect for KKR, including its partnership-oriented approach and experience in supporting value creation across its investments. This is a testament to the hard work of Team Schein to advance our leadership as a solutions-driven innovator for health care professionals. We regularly engage with our shareholders and welcome their constructive dialogue, advice, and recommendations. We look forward to collaborating with Max, Dan, and Bob in pursuing the opportunities ahead of us and building on Henry Schein’s incredible foundation,” Stanley M. Bergman, Henry Schein Chairman of the Board and Chief Executive Officer.